Risk Factors for Delayed Hyperthyrotropinemia in Late Preterm Infants
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to investigate the prevalence of delayed thyroid dysfunction based on iodine disinfectant use and to analyze associated risk factors. Methods: A retrospective study was conducted on late preterm infants admitted to the neonatal intensive care unit between January 2010 and June 2018, who underwent neonatal thyroid screening (NTS) and ≥2 thyroid function tests (TFTs). NTS was performed 3 days after birth, with at least two TFTs 1 week and 2 to 4 weeks after birth. To distinguish between normal and dysfunctional thyroid levels, we reviewed TFT results at 2 to 4 weeks and examined possible risk factors for the development of thyroid dysfunction. Results: Of 295 late preterm infants, 262 were enrolled with a mean gestational age and birth weight of 34.8±0.7 weeks and 2,170±454 g, respectively. A total of 7.6% developed hyperthyrotropinemia at the age of 24.3±14.6 days (range, 12 to 69). The incidence of hyperthyrotropinemia during iodine use was approximately 12.6%, while that during discontinuation was 2.4% (P=0.002). Multivariate analysis revealed that small for gestational age (SGA), iodine disinfectant use, and abnormal NTS results were significant risk factors for delayed hyperthyrotropinemia (adjusted odds ratio [AOR]: 4.27, P=0.008; AOR: 8.24, P=0.003; and AOR: 7.80, P=0.002, respectively). Conclusion: Delayed hyperthyrotropinemia was prevalent in late preterm infants exposed to topical iodine and those identified as being SGA. Secondary TFTs should be considered 2 to 4 weeks after birth for this population at risk.
Abstract
Purpose: This study aimed to investigate the prevalence of delayed thyroid dysfunction based on iodine disinfectant use and to analyze associated risk factors. Methods: A retrospective study was conducted on late preterm infants admitted to the neonatal intensive care unit between January 2010 and June 2018, who underwent neonatal thyroid screening (NTS) and ≥2 thyroid function tests (TFTs). NTS was performed 3 days after birth, with at least two TFTs 1 week and 2 to 4 weeks after birth. To distinguish between normal and dysfunctional thyroid levels, we reviewed TFT results at 2 to 4 weeks and examined possible risk factors for the development of thyroid dysfunction. Results: Of 295 late preterm infants, 262 were enrolled with a mean gestational age and birth weight of 34.8±0.7 weeks and 2,170±454 g, respectively. A total of 7.6% developed hyperthyrotropinemia at the age of 24.3±14.6 days (range, 12 to 69). The incidence of hyperthyrotropinemia during iodine use was approximately 12.6%, while that during discontinuation was 2.4% (P=0.002). Multivariate analysis revealed that small for gestational age (SGA), iodine disinfectant use, and abnormal NTS results were significant risk factors for delayed hyperthyrotropinemia (adjusted odds ratio [AOR]: 4.27, P=0.008; AOR: 8.24, P=0.003; and AOR: 7.80, P=0.002, respectively). Conclusion: Delayed hyperthyrotropinemia was prevalent in late preterm infants exposed to topical iodine and those identified as being SGA. Secondary TFTs should be considered 2 to 4 weeks after birth for this population at risk.
참고문헌 (40)
- Blencowe H, "National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990for selected countries: a systematic analysis and implications", Lancet, 379, pp.2162~2172 (2012)
- Woythaler M., "Neurodevelopmental outcomes of the late preterm infant", Semin Fetal Neonatal Med, 24, pp.54~59 (2019)
- Raju TN, "Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development", Pediatrics, 118, pp.1207~1214 (2006)
- Kugelman A, "Late preterm infants: near term but still in a critical developmental time period", Pediatrics, 132, pp.741~751 (2013)
- McGowan JE, "Early childhood development of late-preterm infants: a systematic review", Pediatrics, 127, pp.1111~1124 (2011)
- Heinonen K, "Late preterm birth and neurocognitive performance in late adulthood: a birth cohort study", Pediatrics, 135, pp.e818~e825 (2015)
- Shah P, "Developmental outcomes of late preterm infants from infancy to kindergarten", Pediatrics, 138, pp.e20153496~ (2016)
- Celik IH, "A common problem for neonatal intensive care units: late preterm infants, a prospective study with term controls in a large perinatal center", J Matern Fetal Neonatal Med, 26, pp.459~462 (2013)
- Fleming PF, "A national survey of admission practices for late preterm infants in England", BMC Pediatr, 14, pp.150~ (2014)
- Cuestas E, "Transient neonatal hyperthyrotropinemia is a risk factor for developing persistent hyperthyrotropinemia in childhood with repercussion on developmental status", Eur J Endocrinol, 172, pp.483~490 (2015)
- Oppenheimer JH, "Molecular basis of thyroid hormone-dependent brain development", Endocr Rev, 18, pp.462~475 (1997)
- Grosse SD, "Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level?", Arch Dis Child, 96, pp.374~379 (2011)
- Van Wassenaer AG, "Hypothyroxinaemia and thyroid function after preterm birth", Semin Neonatol, 9, pp.3~11 (2004)
- Rose SR, "Update of newborn screening and therapy for congenital hypothyroidism", Pediatrics, 117, pp.2290~2303 (2006)
- Mass Screening Committee, "Guidelines for mass screening of congenital hypothyroidism (2014 revision)", Clin Pediatr Endocrinol, 24, pp.107~133 (2015)
- Kucharska AM, "Congenital hypothyroidism:Polish recommendations for therapy, treatment monitoring, and screening tests in special categories of neonates with increased risk of hypothyroidism", Endokrynol Pol, 67, pp.536~547 (2016)
- Leger J, "European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism", Horm Res Paediatr, 81, pp.80~103 (2014)
- Zung A, "Characteristics of delayed thyroid stimulating hormone elevation in neonatal intensive care unit newborns", J Pediatr, 178, pp.135~140 (2016)
- Fenton TR, "A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants", BMC Pediatr, 13, pp.59~ (2013)
- Papile LA, "Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm", J Pediatr, 92, pp.529~534 (1978)
- Kinsella JP, "Bronchopulmonary dysplasia", Lancet, 367, pp.1421~1431 (2006)
- Larson C, "Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism", J Pediatr, 143, pp.587~591 (2003)
- Woo HC, "Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes", J Pediatr, 158, pp.538~542 (2011)
- Sun X, "Free thyroxine and thyroid-stimulating hormone reference intervals in very low birth weight infants at 3-6 weeks of life with the Beckman Coulter Unicel DxI 800", Clin Biochem, 47, pp.16~18 (2014)
- 이지훈, "Thyroid dysfunction in very low birth weight preterm infants", Clinical and Experimental Pediatrics, 58(6), pp.224~229 (2015), 대한소아청소년과학회
- Kaluarachchi DC, "Congenital hypothyroidism with delayed thyroid-stimulating hormone elevation in premature infants born at less than 30weeks gestation", J Perinatol, 37, pp.277~282 (2017)
- Linder N, "Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants", J Pediatr, 131, pp.434~439 (1997)
- Aitken J, "A systematic review of thyroid dysfunction in preterm neonates exposed to topical iodine", Arch Dis Child Fetal Neonatal Ed, 99, pp.F21~F28 (2014)
- Ares S, "Iodine balance, iatrogenic excess, and thyroid dysfunction in premature newborns", Semin Perinatol, 32, pp.407~412 (2008)
- Chung HR, "Subclinical hypothyroidism in Korean preterm infants associated with high levels of iodine in breast milk", J Clin Endocrinol Metab, 94, pp.4444~4447 (2009)
- Bagnoli F, "Altered thyroid function in small for gestational age newborns:study based on screening test for congenital hypothyroidism", J Pediatr Sci, 4, pp.e55~ (2010)
- Franco B, "Thyroid function in small for gestational age newborns: a review", J Clin Res Pediatr Endocrinol, 5(Suppl 1), pp.2~7 (2013)
- Uchiyama A, "Small for gestational age is a risk factor for the development of delayed thyrotropin elevation in infants weighing less than 2000 g", Clin Endocrinol (Oxf), 89, pp.431~436 (2018)
- Aktas ON, "Thyroid hormone levels in late preterm, early term and term infants: a study with healthy neonates revealing reference values and factors affecting thyroid hormones", J Pediatr Endocrinol Metab, 30, pp.1191~1196 (2017)
- Vigone MC, "Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism", J Pediatr, 164, pp.1296~1302 (2014)
- Bijarnia S, "Newborn screening for congenital hypothyroidism in very-low-birth-weight babies: the need for a second test", J Inherit Metab Dis, 34, pp.827~833 (2011)
- Hashemipour M, "Screening of congenital hypothyroidism in preterm, low birth weight and very low birth weight neonates:a systematic review", Pediatr Neonatol, 59, pp.3~14 (2018)
- Chung ML, "Thyroid dysfunctions of prematurity and their impacts on neurodevelopmental outcome", J Pediatr Endocrinol Metab, 26, pp.449~455 (2013)
- Lim G, "discontinuation of thyroxine therapy is possible in most very low-birthweight infants with hypothyroidism detected by screening", Acta Paediatr, 103, pp.e123~e129 (2014)
- Jung JM, "Feasibility of an early discontinuation of thyroid hormone treatment in very-low-birthweight infants at risk for transient or permanent congenital hypothyroidism", Horm Res Paediatr, 85, pp.131~139 (2016)